Sulfhydryl requirement for relaxation of vascular smooth muscle.
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001808:Blood Vessels / Q000502:physiology*; D003545:Cysteine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D009573:Nitrites / Q000378:metabolism; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D014665:Vasodilator Agents / Q000494:pharmacology
D009573:Nitrites; D013438:Sulfhydryl Compounds; D014665:Vasodilator Agents; D005665:Furosemide; D005996:Nitroglycerin; D003545:Cysteine; D004976:Ethacrynic Acid; D009638:Norepinephrine